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Abstract: New-generation implants focus on robust, durable, and rapid tissue regeneration to 
shorten recovery times and decrease risks of postoperative complications for patients. Herein, 
we describe a new-generation thick nanofibrous implant functionalized with active containers 
of growth factors and stem cells for regenerative nanomedicine. A thick electrospun poly(ε-
caprolactone) nanofibrous implant (from 700 μm to 1 cm thick) was functionalized with chitosan 
and bone morphogenetic protein BMP-7 as growth factor using layer-by-layer technology, 
producing fish scale-like chitosan/BMP-7 nanoreservoirs. This extracellular matrix-mimicking 
scaffold enabled in vitro colonization and bone regeneration by human primary osteoblasts, 
as shown by expression of osteocalcin, osteopontin, and bone sialoprotein (BSPII), 21 days 
after seeding. In vivo implantation in mouse calvaria defects showed significantly more newly 
mineralized extracellular matrix in the functionalized implant compared to a bare scaffold 
after 30 days’ implantation, as shown by histological scanning electron microscopy/energy 
dispersive X-ray microscopy study and calcein injection. We have as well bifunctionalized our 
BMP-7 therapeutic implant by adding human mesenchymal stem cells (hMSCs). The activity 
of this BMP-7-functionalized implant was again further enhanced by the addition of hMSCs to 
the implant (living materials), in vivo, as demonstrated by the analysis of new bone formation 
and calcification after 30 days’ implantation in mice with calvaria defects. Therefore, implants 
functionalized with BMP-7 nanocontainers associated with hMSCs can act as an accelerator 
of in vivo bone mineralization and regeneration.
Keywords: regenerative nanomedicine, electrospun nanofibers implant, nanocontainers of 
growth factors, BMP-7
Introduction
Bone regeneration is a complex, well-orchestrated physiological process of bone 
formation, which can be seen during normal fracture healing, and is involved in 
continuous remodeling throughout adult life. Nevertheless, there are difficult clini-
cal situations in which bone regeneration is required in large quantities, such as for 
skeletal reconstruction of large bone defects created by trauma or tumor resection, or 
in cases in which the regenerative process is compromised (nonunions, osteoporosis). 
The common bone regeneration techniques used today include the implantation of free 
fibula vascularized grafts, autologous bone grafts, allograft implantations, and use of 
growth factors, scaffolds, and osteoprogenitor cells, but all of these are limited.1 The 
tissue engineering approach is a promising strategy in the field of bone regenerative 
medicine which aims to generate new functional tissues, rather than just to implant 
nonliving scaffolds.2 This alternative could overcome the limitations of current thera-
pies, by combining the knowledge in orthopedic surgery with materials science and 
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biology, and its clinical application offers great potential.2–4 
For example, distraction osteogenesis and bone transport 
requiring long treatment possibly have an effect on patients’ 
psychology. Bone grafting requires additional surgical pro-
cedures, leading to discomfort for the patient, and is limited 
by the availability of bone. Bone graft substitutes like metals 
exhibit poor integration, and beta-tricalcium phosphate or 
ceramics are brittle.2–4 For these reasons, adding cells to mate-
rials represents an alternative solution for efficient and robust 
bone repair. 2–4 Basically, bone tissue engineering combines 
progenitor cells, such as mesenchymal stem cells (MSCs) 
(native or expanded) or mature cells (osteoblasts) seeded 
in biocompatible scaffolds and ideally in three-dimensional 
tissue-like structures with appropriate growth factors like 
bone morphogenetic proteins (BMPs) in order to generate 
and maintain bone natural regeneration.5
To date, three polymer processing technologies (self-
assembly, phase separation, and electrospinning) allow 
the fabrication of nanofibrous scaffolds.6–9 Our strategy for 
regenerating bone combines a synthetic electrospun nanofi-
brous membrane (ENM) composed of the US Food and Drug 
Administration (FDA)-approved poly(ε-caprolactone) (PCL) 
polymer, and the bioactive growth factor BMP-2 entrapped 
into polymer nanoreservoirs built atop the nanofibers accord-
ing to layer-by-layer (LbL) technology and fortified.10–21
In bone repair, for a small lesion, we do not need bone 
substitute, as, at this early stage, the regenerative medicine 
is suitable for regenerating bone tissue. In regenerative 
medicine, the European and American authorities have 
already approved the use of BMP-2 or BMP-7 for bone 
regeneration applications. For example, Medtronic offers 
InductOs®, which is a basic collagen matrix (of animal ori-
gin) soaked in BMP-2 (12 mg), and Stryker offers the same 
collagen membrane soaked in BMP-7. The efficacy of this 
kind of combination device is dependent on slow release 
kinetics of BMPs. This criterion is recognized as the criti-
cal, most challenging requirement for combination implants. 
For efficient bone regeneration, the target cells require a 
reliable and continuous exposure to growth factors over an 
extended period of time, until the induction of new bone. 
The currently available devices are totally unsophisticated 
in this respect. In contrast, our innovative medical device, 
with cell contact-dependent delivery from nanoreservoirs, is 
designed specifically for reliable and sustained availability of 
BMP-2.16,21,22 This strategy aims at a dramatic enhancement 
of therapeutic efficacy at reduced cost.
Recently, we reported the capability of a thin (50 μm 
thick) electrospun nanofibrous PCL membrane functionalized 
with nanoreservoirs of BMP-2 to increase the speed of bone 
regeneration both in vitro and in vivo.21 The aim of the pres-
ent study was to use the same PCL polymer to electrospin 
a thick nanofibrous membrane (from 700 μm to 1 cm) for 
large lesions.
In this study, we chose BMP-7 as growth factor to func-
tionalize the thick PCL membrane. This is the first investiga-
tion of combined biodegradable, thick PCL membrane and 
active molecules for regenerative medicine. We have as well 
fortified this membrane by adding human MSCs (hMSCs). 
This hybrid and living implant was then analyzed in term of 
bone induction and the capability to increase the speed of 
bone regeneration.
In regenerative medicine, the need for such improved 
composite grafts is obvious, especially for the management 
of large bone defects (1–2 cm diameter, 2–4 mm thick-
ness), for which the requirements for grafting material are 
substantial.
Today, composite grafts that are available include syn-
thetic bone or bioabsorbable scaffolds seeded with bone 
marrow aspirate or growth factors like BMPs, providing 
a competitive alternative to autologous bone grafts.23 We 
report herein a new thick, nanofibrous electrospun PCL 
implant (700 μm thick) functionalized with low-dose bio-
active nanocontainers of BMP-7 and seeded with hMSCs 
as a new strategy to regenerate robust tissue in large-size 
bone defects.
Recently, great progress has been made in a new genera-
tion of biomaterials based on nanotechnology. Nanofibrous 
biomaterials play central roles in modern strategies in 
regenerative nanomedicine. The guidance provided by these 
biomaterials could facilitate restoration of structure and 
function in damaged or dysfunctional tissues. Such materials 
should provide provisional 3D support to interact with cells in 
ways that control their function, by spatially and temporally 
guiding the complex cellular processes of tissue formation 
and regeneration.24–31 Synthetic bone regenerative scaffolds 
have been used and investigated over the last century. Several 
biomimicking medical devices for regenerative medicine 
have been inspired from the intricate fibrillar architecture 
of the natural extracellular matrix (ECM).32 Such matrices 
have already shown remarkable success in tissue engineering 
applications, examples of which include the reconstruction of 
a dog urinary bladder, or the regeneration after brain injury 
in a mouse stroke model.27,33,34 However, it is established 
that inert ECM mimetic scaffolds do not efficiently gener-
ate durable tissue repair.27,32,33 Therefore, there is a need for 
materials ensuring the sustained release of active compounds. 
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To this end, recent advances in nanotechnology have led to 
various engineered ECM analogs (electrospun nanofibers) 
and biomaterials functionalized with active therapeutics 
(drugs, genes, or growth factors).13,15,16,19,21,35–42
Polymer processing technologies such as electrospinning 43 
allow nanofiber formation down to the 10 nm scale. Recently, 
we reported that it is possible to incorporate active growth 
factors (BMP-2, TGF-β1) as nanoreservoirs to induce bone 
formation.20,21,44–46 We have also shown that electrospun thin 
PCL membranes (50 μm) increase the speed of bone regen-
eration when they incorporate BMP-2 within nanocontainers. 
We also showed no passive uncontrolled release of those 
growth factors from the active nanocontainers, but an active 
cell contact-dependent release.21 In this study, we used the 
polymer PCL to manufacture thick electrospun nanofibers 
as scaffolds.
Electrospun nanofibers have an extremely high specific 
surface area-to-volume ratio because of their small diameters, 
and the resulting 3D thick nanofiber implants are highly 
porous with excellent pore interconnectivity. These unique 
characteristics reveal nanofiber-based implants with many 
desirable properties for advanced applications.
Recently, different groups have developed different strat-
egies by using not only PCL and MSCs but also BMPs to 
induce bone regeneration. Our strategy combines both active 
nanoreservoirs of BMPs (cell contact-dependent release) and 
stem cells as a new strategy to increase the speed of bone 
regeneration. Previously, we used BMPs and primary cells. 
Concerning the electrospun PCL nanofibrous scaffold, in our 
previous studies, we used a thin membrane (50 μm); in this 
study,23 we used a thick membrane. This system combined 
thick synthetic ENMs of the FDA-approved PCL polymer 
and the bioactive growth factor BMP-7 confined atop the 
nanofibers according to LbL technology.12 The latter con-
sisted of a repeated sequence of simple alternate immersions 
of the ENM scaffold into 1) a solution of chitosan (CHI), 
a biocompatible polysaccharide with bone regenerative 
properties,20,43 and 2) a solution of BMP-7 (with rinsing steps 
between consecutive adsorption steps).
We studied the LbL build-up of the BMP-7-based archi-
tectures by means of Quartz Crystal Microbalance with Dis-
sipation monitoring (QCM-D) and inspected the structure of 
the electrospun nanofiber scaffolds with scanning electron 
microscopy (SEM). The potency of the BMP-7-loaded 
nanofibrous scaffolds with regards to bone regeneration 
was assessed both in vitro and in vivo by inspecting cell 
adhesion, proliferation and specific gene expression, and 
bone regeneration after implantation in mice.
Materials and methods
3D nanofibrous PCL scaffold preparation 
and BMP-7 nanoreservoir build-up
PCL, analytical grade, was obtained from Perstorp 
(Malmö, Sweden). A solution of PCL (23% wt/v, in 
dimethylformamide:methylene chloride 1:1 v/v) was elec-
trospun at high voltage (20 kV at the beginning) which was 
increased during the process (26 kV at the end). During the elec-
trospinning process (EC-DIG electrospinning apparatus; IME 
Technologies, Eindhoven, the Netherlands), the delivery of the 
PCL solution was controlled at a constant rate of 1.2 mL/h, in 
an atmosphere at 35% humidity at 30°C. The distance between 
the needle and the collector was set at 16 cm. The electrospun 
jet was focused by the use of a poly(methyl methacrylate) 2.5 
mm-thick mask drilled with a hole (diameter of 25 mm) placed 
over the conductive collector. The 3D electrospun nanofibers 
were then kept overnight in a desiccator at 45°C to evaporate all 
residual solvent. For the build-up of the BMP-7 nanoreservoirs, 
the LbL technique was used. The PCL electrospun scaffold was 
dipped four times during 15 minutes in alternate solutions of 
CHI (Protasan UP CL 113; Novamatrix, Sandvika, Norway; 
500 mg/mL) and BMP-7 (Euromedex, Souffelweyersheim, 
France; 200 ng/mL) in MES buffer (2-N-morpholino ethane 
sulfonic acid; Sigma-Aldrich Co., St Louis, MO, USA; 0.04 M, 
NaCl 0.15 M) at pH 5.5. Each bath was followed by a rinsing 
step in a solution of MES buffer (0.04 M, NaCl 0.15 M).
cell culture
Human primary osteoblasts and human bone marrow MSCs 
were obtained from PromoCell (Heidelberg, Germany). Osteo-
blasts were cultured in a specific osteoblast growth medium 
(PromoCell) containing supplement mix ( PromoCell), and 
50 U/mL penicillin and 50 μg/mL streptomycin (Ozyme, 
Montigny-le-Bretonneux, France). The cells were incubated 
at 37°C in a humidified atmosphere of 5% CO
2
. When cells 
reached subconfluence, they were harvested with trypsin 
(Ozyme) and subcultured. hMSCs were cultured with MSC 
growth medium (PromoCell) containing MSC supplement 
mix (PromoCell), 50 U/mL penicillin and 50 μg/mL strep-
tomycin. The cells were incubated at 37°C in a humidified 
atmosphere of 5% CO
2
. When cells reached subconfluence, 
they were harvested with trypsin and subcultured.
Cell viability and proliferation
Cell viability was checked by Trypan blue exclusion test. 
AlamarBlue® (Thermo Fisher Scientific, Waltham, MA, 
USA) was used to assess cell proliferation over time. The 
AlamarBlue® test is a nontoxic, water-soluble, colorimetric 
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redox indicator that changes color in response to cell 
metabolism. In this study, 4×104 human osteoblasts and 
3×103 hMSCs were seeded on top of the PCL scaffolds 
placed on 48-well plates. After 3, 7, and 21 days of culture, 
cells were incubated in 10% AlamarBlue®/Dulbecco’s Modi-
fied Eagle’s Medium (medium without phenol red; Lonza, 
Levallois-Perret, France) solution in a humidified atmosphere 
at 37°C and 5% CO
2
. After 4 hours, 200 μL of incubation 
media were transferred to 96-well plates and measured at 
590 nm and 630 nm in order to determine the percentage of 
AlamarBlue® reduction. Statistical analyses were obtained 
by the twoway ANOVA test in Excel 2011, Microsoft Office 
(Microsoft Corporation, Redmond, WA, USA).
In vivo implantation on skulls of nude 
mice
In regards to animals and tissues, all procedures were 
designed in compliance with the recommendations of the 
European Union (2010/63/EU) for the care and use of labo-
ratory animals.
In regards to ethics, experiments followed current Euro-
pean Union regulations (Directive 2010/63/EU), and were 
performed according to authorized investigator Dr N Jessel 
(Director of the Osteoarticular and Dental Regenerative 
Nanomedicine team), holder of a personal license from 
Préfecture du Bas-Rhin (number 67–315), who oversaw 
experiments done on mice. All experiments were done in the 
Animalerie Centrale de la Faculté de Médecine de Strasbourg 
with the approval number A 67-482-35 from the Veterinary 
Public Health Service of the Préfecture du Bas-Rhin, repre-
senting the French Ministry of Agriculture, Department of 
Veterinary Science. For further tissue implantations, all sur-
gery was performed under ketamine and xylazine anesthesia, 
and all efforts were made to minimize suffering.
The study was run with nude male mice (Crl: NIH-Foxn1nu; 
Charles River, L’Arbresle, France) 6 weeks of age. The 
mice were anesthetized with an intraperitoneal injection of 
100 mg/kg of ketamine (VIRBAC Santé Animale; Centravet 
Centravet, Nancy, France) and injection of 10 mg/kg of xyla-
zine (Rompun® 2%;) and animals were placed in ventral decu-
bitus on a heating table, with strict aseptic conditions. After 
skin incision, two bony defects (2 mm size) were created in the 
parietal zone of the skull using an electric drill with a sterile 
round burr under irrigation of sterile normal saline before depo-
sition of two samples of nanofibrous PCL implant (either not 
functionalized [NF] or functionalized with nanocoreservoirs 
of BMP-7 [NR4] and/or hMSCs) and sutured with Ethicon 9/0 
(Ethicon France, Issy Les Moulineaux, France). hMSCs were 
seeded on the implant 2 hours before implantation. The skin 
was sealed with sutures and the animals’ behavior observed 
after waking up. The mice were sacrificed with an intraperi-
toneal injection of a lethal dose of ketamine and the samples 
were extracted after 30 days of implantation.
histology
For histology, samples (the implants) were fixed for 24 hours 
in Bouin-Hollande and embedded in paraffin. Serial sections 
(7 μm) were stained with Mallory’s stain. After long-term 
implantations, the samples were demineralized in 15% EDTA 
for 48 hours. After the removal of paraffin wax, sections of 
the calvaria implants were stained using Mallory coloration 
over 2 days. The percentage of mineralized area on histologi-
cal sections was measured with ImageJ software by selecting 
the mineralized area and total implant area.
seM
To analyze the morphology, the scaffolds were gold-coated 
(Edwards Sputter Coater) after fixation in 2.5% glutaralde-
hyde for 2 hours at 37°C, osmium tetroxide 1% incubation 
for 1 hour, and dehydration, and observed with a scanning 
electron microscope (SEM Hitachi TM1000) in conventional 
mode (high vacuum).
Immunofluorescence staining
Samples seeded with human osteoblasts or hMSCs were culti-
vated for 21 days. Then, they were fixed with 4% paraformal-
dehyde for 1 hour, permeabilized with 0.1% Triton X-100 for 1 
hour, and incubated for 30 minutes with Alexa Fluor 546-conju-
gated phalloidin (Molecular Probes; Life Technologies, Fisher 
Scientific, Illkirch, France) for F-actin labeling and 5 minutes 
with 200 nM DAPI (Sigma-Aldrich Co.) for nuclear staining. 
Bone growth induction was measured by assaying expression 
of osteopontin, osteocalcin, and BSPII, using polyclonal goat 
anti-osteopontin (1/200; Santa Cruz Biotechnology Inc., Dallas, 
TX, USA), polyclonal goat anti-osteocalcin (1/200; Santa Cruz 
Biotechnology), and monoclonal mouse anti-BSPII (1/200; 
Santa Cruz Biotechnology Inc.) overnight at 4°C. After washing 
with polyphosphate buffer (phosphate-buffered saline [PBS]; 
Sigma-Aldrich Co.), the samples were incubated with secondary 
anti-goat or anti-mouse antibodies conjugated to Alexa Fluor 
488 (Life Technologies). The samples were observed under an 
epifluorescence microscope (LEICA DM 4000 B).
calcein injection
Subcutaneous injections of calcein (10 mg/kg; Sigma-Aldrich 
Co.) in PBS were given on the tenth and third days before 
necropsy. After 30 days of calvaria implantation, mice were 
sacrificed, and the samples were extracted. The samples 
International Journal of Nanomedicine 2015:10 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1065
Nanofibrous implants for bone regeneration
were then embedded in Tissue-Tek® OCT (Fisher Scientific, 
Illkirch, France), frozen at -20°C, and cut into sections with 
a cryostat (Leica JUNG CM3000). Cell nuclei were stained 
with 200 nM DAPI (Sigma-Aldrich Co.) for 5 minutes. The 
sections were mounted with anti-fading medium and observed 
under an epifluorescence microscope (LEICA DM 4000 B).
seM/energy dispersive X-ray 
spectroscopy
The different implants were morphologically and composi-
tionally analyzed using a field-emission scanning electron 
microscope (Inspect™ F50; FEI, Hillsboro, Oregon, USA) 
equipped with an energy-dispersive X-ray spectrometer to map 
the elemental composition of the samples during the inspec-
tion. The surfaces were Pt-sputtered before observation and 
examined at an accelerating voltage of 10 kV and a working 
distance of 10 mm. The fiber diameter was measured with 
ImageJ software.47
Nanoindentation
A Berkovich indenter was used in this study. Nanoindentation 
cycles are divided currently into three steps: loading, creep, 
and unloading. In these tests, a linear loading step was carried 
out to achieve the maximum load per cycle. At the end of 
loading, the creep step is started. This step is characterized 
by leaving the applied load constant over a certain time. 
The last step is the unloading, during which the mechanical 
properties are measured. The method used to characterize 
these tests is the Oliver–Pharr method.48 The maximum load 
was distributed from 5 mN to 60 mN (quadratic growth). The 
loading and unloading time was equal to 30 seconds and the 
creep time was 50 seconds. At least ten cycles of indentation 
test were performed at the same area, by increasing the load, 
to obtain the changes of mechanical properties as a function 
of the indentation depth. The time between each indentation 
cycle carried out at the same place was 5 seconds.
statistical analysis
Averages and standard deviations were calculated from three 
repeats on each sample, except for AlamarBlue® quantifica-
tion, where duplicate readings were performed for each repeat. 
Error bars on graphs represent standard deviation. A two-way 
ANOVA test was performed in Excel 2011, Microsoft Office.
Results
BMP-7 nanoreservoir construction 
for osteogenic differentiation
First, a thick electrospun PCL nanofibrous implant (700 μm 
thick; fibers 689±45 nm in diameter) was manufactured as 
scaffold material to generate the tissue-engineered implant 
(Figure 1). The effective deposition, and nanoscale dimen-
sions, of LbL architectures onto the thick electrospun 
nanofibrous scaffold were confirmed by means of SEM 
(Figure 2). While the bare (NF) nanofibers displayed a 
smooth topography, (CHI/BMP-7)
4
-treated nanofibers (called 
NR4) showed uniformly distributed nanostructured deposits 
on their surfaces. CHI-based deposits had a fish scale-like 
morphology.
In vitro colonization and osteogenic 
expression induced by BMP-7 
nanoreservoirs
Before investigating the behavior of the hMSCs, we analyzed 
the human primary osteoblasts’ colonization onto the PCL 
thick scaffold and their morphology after 3, 7, and 14 days 
onto this nanofibrous scaffold with or without functionaliza-
tion with the morphogenetic protein BMP-7 (Figure 3).
To investigate the behavior of human primary osteo-
blasts in contact with the nanofibrous thick scaffold and the 
BMP-7 effect, we analyzed the progress of adhesion and 
colonization of these cells over time. First, the AlamarBlue® 
reduction percentage, followed over time at 3, 7, and 14 days 
(Figure 3A), confirmed the viability of the cells on both types 
of scaffolds (without [NF] or functionalized with [NR4] 
BMP-7); however, the results do not reveal any significantly 
enhanced effect of the functionalization (P0.05 at each time 
and between days 7 and 14). SEM micrographs (Figure 3B) 
indicate that, already after 3 days, cell adhesion was different 
for the functionalized (NR4) and NF scaffolds. After 3 days, 
the osteoblasts adhered onto the NR4 scaffold in clusters, 
whereas on NF scaffold cells, they were just individually 
in contact with the nanofibers. However, from day 7 until 
day 14, cell colonization became similar for both scaffolds, 
resulting in larger, far more spread and elongated cells 
Figure 1 Macroscopic aspect of thick poly(ε-caprolactone) electrospun nanofibrous 
membrane.
Notes: 700 μm thickness (A) and 1 cm thickness (B).
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anchored to the nanofibers through numerous filopodia exten-
sions, which represent a typical morphology for this kind of 
cell. To further investigate the extent of bone regeneration, 
the expression of osteocalcin, osteopontin, and BSPII was 
examined 21 days after seeding (Figure 4). The immuno-
fluorescence images show that osteogenesis occurs success-
fully in both types of scaffold (NF and NR4); however, the 
enhancement of protein expression by the functionalization 
is significant in vitro, even after 21 days.
BMP-7 nanoreservoirs can accelerate 
in vivo bone regeneration and 
mineralization
To further study matrix synthesis and bone induction, 
implantations were carried out in vivo in mice. NF and NR4 
nanofibrous PCL thick scaffolds were implanted into mouse 
calvaria defects for 15 or 30 days. At these times, mice 
were sacrificed and histological study was then carried out 
to analyze the host cell colonization within the implants in 
the bone defect site, the osseointegration of the implant, the 
matrix synthesis, and the new bone mineralization. Mallory 
coloration was used in order to identify mineralized bone, 
ECM, and cell nuclei. A difference between NF and NR4 
implants could be already seen at the stage of colonization 
and migration of osteoblasts from the site of implantation 
within the implants after 15 days of implantation (data not 
shown). After those days, the host osteoblasts had just begun 
to migrate inside the NF implant, whereas the colonization 
within the NR4 implant was clearly higher. Additionally, 
it appeared that the osteoblasts during migration followed 
the nanofibers’ direction, and no inflammatory reaction was 
detected. There was even an area showing newly mineralized 
Figure 2 Scanning electron microscopy images of PCL electrospun nanofibrous 3D scaffolds.
Notes: 500 μm (A and B), 20 μm (C and D), and 500 nm (E and F) NF and Nr4 scaffolds (A, C, and E and B, D, and F, respectively).
Abbreviations: NF, not functionalized; NR4, functionalized with (chitosan/BMP-7)4 nanocontainers; Pcl, poly(ε-caprolactone).
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ECM, clearly identified (orange staining similar to the native 
host bone). After 30 days (Figure 5), there was significantly 
more newly mineralized area within NR4 compared to the NF 
implant. In order to evaluate the amount of biomineralized 
matrix in the different implants after 30 days, quantitative 
measurements were made, showing that only 18% of the 
area of the NF implant was mineralized, whereas 31% for 
the NR4 implant was achieved.
To further investigate these results, SEM/EDS analysis 
was used to monitor calcification over time in the in vivo 
model. The SEM/EDS maps of the implanted scaffolds 
(Figure 6) showed a clear colocalization of the calcium (Ca) 
and phosphate (P) signals, indicative of bone formation. 
To determine the degree of conversion into natural bone 
30 days after implantation, the Ca/P weight ratios were 
calculated. The NF and NR4 scaffolds showed ratios of 
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Notes: In vitro expression of OCN, BSPII, and OPN in HOBs after 21 days of cell culture onto the PCL bare scaffolds (NF) or those equipped with BMP-7 nanocontainers (NR4). 
The nucleus was stained with DAPI (in blue), actin labelled with phalloidin (in red), and OCN, BSPII, and OPN were stained in green. For all images, scale bars =100 μm.
Abbreviations: BSPII, bone sialoprotein II; HOBs, human primary osteoblasts; NF, not functionalized; NR4, functionalized with (chitosan/BMP-7)4 nanocontainers; OcN, 
osteocalcin; OPN, osteopontin; Pcl, poly(ε-caprolactone).
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1.10 and 1.75, respectively (Figure 6A). These results were 
confirmed by calcein injection after 30 days of culture show-
ing more pronounced mineralization and calcic bone area in 
the middle part of the NR4 implant (Figure 6B). These results 
indicate clearly that, by using the thick PCL membrane, after 
30 days implantation in the skull of mice, we did not have 
complete regeneration on the bone defect (Figure 6). That 
means, by using a thick graft, the functionalization with 
BMPs only is not enough to sufficiently accelerate the speed 
of bone regeneration.
To better understand these results, we analyzed the 
elastic modulus (E) of our retrieved implants (NF and NR4) 
after 30 days of implantation in mouse calvariae (Figure 7). 
After this duration, the evolution of the E as a function of 
the penetration depth in the (CHI/BMP-7)
4
-functionalized 
implant (NR4) and in the implant without functionalization 
(NF) was followed. First, we observed that, for all tested 
penetration depths, the values of the E for functionalized 
implants (NR4) were always greater than for the NF one. 
In Figure 7, the crosses illustrate the confidence interval 
with 95% of certainty. The regions delimited by each group 
are clearly separated, indicating that the functionalization 
was effective, leading clearly to overall enhanced E. We 
observed that the E decreased with the indentation depth for 
both implants. At the surface, bone regeneration seems faster 
than in the bulk. In fact, the implant surface was more easily 
colonized by host osteoblasts than beneath. When cell adhe-
sion and differentiation were achieved, a high value for the 
E at the surface was obtained. Then, it is possible to divide 
the results of E into two parts: the surface (0 penetration 
depth 5 μm) and the volume (penetration depth 5 μm). 
For NR4 and NF scaffolds, the E values varied from 4 GPa 
in the first microns to 0.70 GPa at a 5 μm depth, and from 
1 GPa in the first microns to 0.21 GPa at 5 μm, respectively. 
For an indentation depth larger than 5 μm, the E values seem 
to be constant: E =0.15–0.34 GPa for the NF implant and 
E =0.5–1 GPa for the NR4 implant. As a control, the E of the 
native bone was measured. In this case, the E values varied 
from 8.2 to 22 GPa.
Thus, implants composed of 3D nanofibrous PCL and 
BMP-7 nanoreservoirs can represent a biocompatible mate-
rial able to accelerate and improve in vivo bone regeneration 
and mineralization. To further accelerate the speed of bone 
regeneration, the third generation of biomaterials should 
be used, by combining not only growth factors, but also 
living cells.
BMP-7 nanoreservoirs and hMscs 
can improve and accelerate bone 
regeneration in vivo
After having analyzed the effect of the 3D PCL nanofibrous 
scaffold and of the BMP-7 nanoreservoirs on bone regenera-
tion and mineralization in vivo, we investigated if the addition 
of hMSCs on this functionalized material could improve the 
efficiency of bone regeneration in vivo.
We first analyzed the potential of hMSCs to infiltrate 
the PCL thick nanofibrous scaffold in vitro. After seeding 
hMSCs on the thick NR4 or NF scaffold, we found that cells 
colonized both NF and NR4 scaffolds, as demonstrated by the 
AlamarBlue® experiments (P0.05 at each time) (Figure S1). 
HB HB
HB
100 µm 100 µm
HBNF NR4
Figure 5 Histological analysis of the effect of BMP-7 nanoreservoirs in vivo on bone tissue regeneration.
Notes: Histological analysis of in vivo bone induction onto functionalized PCL scaffold (NR4) compared to bare PCL (NF) scaffold after 30 days of calvaria implantation 
in mice. Mallory coloration was used in order to identify mineralized extracellular matrix (pink) and cell nuclei (blue).The square area in the drawn scheme represents the 
histological section inside the mouse calvaria defects.
Abbreviations: HB, host bone; NF, not functionalized; NR4, functionalized with (chitosan/BMP-7)4 nanocontainers; Pcl, poly(ε-caprolactone). 
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Although no significant positive effect of NR4 functionaliza-
tion on hMSC proliferation was found, these results show 
the biocompatibility of the NR4 3D PCL scaffold with these 
cells. After 21 days, the immunofluorescence images showed 
good protein expression of the hMSCs seeded onto both scaf-
folds (NF and NR4), but again there is no really significant 
effect of the NR4 architecture in vitro (Figure S2).
To study the ability of hMSCs to improve bone regen-
eration and mineralization in the functionalized implants 
in vivo, we analyzed calcification of the implants after 
30 days in vivo by SEM/EDS maps (Figure 8). Colocaliza-
tion of the Ca and the P signals was observed on the NF and 
NR4 scaffolds with hMSCs, obtaining a Ca/P weight ratio 
of 1.35 and 1.65, respectively. To visualize the formation of 
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SEM
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Calcein
DAPI
Calcein
Ca
Ca
C
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400 µm
400 µm
100 µm
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HB
NF
HB
HBNF
NR4
HB
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NR4
Figure 6 BMP-7 nanoreservoirs’ effect in vivo on bone mineralization.
Notes: (A) seM micrographs, after 30 days of implantation in mouse skull, showing the morphology and composition of the scaffolds; corresponding elemental mapping 
of P (green), Ca (red), and C (blue) is depicted. Overall SEM visualization of the grafts is in gray. (B) In vivo bone induction onto NF scaffold or onto NR4 PCL scaffold 
30 days after calvaria implantations in nude mice. Cell nucleus is in blue, stained with DAPI; bone in formation is shown in green, stained with calcein. For all images, scale 
bars =100 μm.
Abbreviations: C, carbon; Ca, calcium; HB, host bone; NF, not functionalized; NR4, functionalized with (chitosan/BMP-7)4 nanocontainers; P, phosphorus; Pcl, poly(ε-
caprolactone); seM, scanning electron microscopy.
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new bone, calcein was intraperitoneally injected (Figure 9). 
Figure 9 shows the positive effect of the NR4 architecture 
compared to the NF scaffold in the presence of hMSCs. We 
had already seen a positive effect of the NR4 functionaliza-
tion compared to bare scaffold in the absence of hMSCs 
(Figure 6B). However, the supplementary positive effect 
of the hMSCs can be highlighted when comparing Figure 9 
and Figure 6B. Therefore, the double functionalization with 
BMP-7 and hMSCs can act as an accelerator of in vivo bone 
mineralization and regeneration.
Discussion
Thick (chI/BMP-7)4 Pcl implant as a 
new material for regenerative medicine
In the last decade, a variety of active biomaterials incorpo-
rating biological active molecules have been developed.23–49 
Recently, using an electrospun PCL nanofibrous thin 
implant, excellent bone regeneration for small lesions was 
accomplished, with complete colonization and bone induc-
tion inside the scaffold after in vivo implantation in mice.21 
For large lesions, however, the challenge is to develop an 
approach to induce bone regeneration deep within the implant 
by using a thick rather than a thin implant.
To achieve robust bone formation on a thick nanofibrous 
bone implant (~700 μm to 1 cm thick), we evaluated a new 
tissue engineering concept combining not only the incor-
poration of growth factors (BMP-7) within nanoreservoirs, 
but also hMSCs from bone marrow within electrospun PCL 
nanofibrous scaffolds. Thus, we evaluated whether bone 
formation can be further improved by incorporating living 
hMSCs into the electrospun thick nanofibrous implant.
Electrospun nanofibers have an extremely high specific 
surface area, which allows the scaffold to mimic the col-
lagen ECM. The resulting 3D, thick nanofibrous implants 
are highly porous (above 90%) with excellent pore intercon-
nectivity showing a superposition of thin nanofiber layers. 
Interactions between the different nanofiber layers occur 
randomly during the electrospinning process, which leads 
to a random pore size distribution. These unique character-
istics of nanofiber-based implants are desirable properties 
for advanced applications.21
Thick (chI/BMP-7)4 PCL nanofibrous 
implant for bone regeneration
The characterization of the thick PCL electrospun scaf-
fold showed a highly porous organization with a structure 
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Figure 7 Nanoindentation analysis of the BMP-7 nanoreservoirs’ effect on the implants.
Notes: elastic modulus as a function of penetration depth of nanoindentations carried out on Nr4 and NF implants after 30 days’ implantation in mouse calvariae. The 
crosses illustrate the confidence interval with 95% of certainty.
Abbreviations: NF, not functionalized; NR4, functionalized with (chitosan/BMP-7)4 nanocontainers.
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Figure 8 In vivo analysis of combined BMP-7 and hMSCs on bone tissue calcification.
Notes: seM micrographs showing the morphology and elemental composition of the NF and Nr4 scaffolds seeded with hMscs after 30 days of implantation in mouse skull. 
Elemental mapping of P (green), Ca (red) and C (blue) is depicted. Overall SEM visualization of the grafts is in gray. For all images, scale bars =400 μm.
Abbreviations: C, carbon; Ca, calcium; HB, host bone; hMSCs, human mesenchymal stem cells; NF, not functionalized; NR4, functionalized with (chitosan/BMP-7)4 
nanocontainers; P, phosphorus; seM, scanning electron microscopy.
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Figure 9 In vivo analysis of BMP-7 nanoreservoirs’ and hMSCs’ effect on bone tissue mineralization.
Notes: In vivo bone induction onto NF PCL scaffold with hMSCs (A) or onto Nr4 Pcl scaffold with hMscs (B) 30 days after calvaria implantation in nude mice. cell nucleus 
is in blue, stained with DAPI; bone in formation is shown in green, stained with calcein. For all images, scale bars =100 μm.
Abbreviations: HB, host bone; hMSCs, human mesenchymal stem cells; NF, not functionalized; NR4, functionalized with (chitosan/BMP-7)4 nanocontainers; Pcl, poly(ε-
caprolactone).
composed of a superposition of thin nanofibrous layers. 
Interactions between the different nanofibrous layers occurred 
randomly during the electrospinning process, which leads to 
a random distribution of the pores in terms of size. However, 
because of the interactions between the nanofibrous layers, 
the pores were not round but presented an elongated shape. 
Moreover, the elongated filopodia intimately anchored to the 
nanofibers confirmed a high compatibility between human 
primary osteoblasts and this thick electrospun nanofibrous 
PCL scaffold. These results are in agreement with previ-
ous literature.43 However, it seemed that the infiltration of 
the cells into the porous structure was relatively limited, 
particularly on day 14 when the cells were at confluence 
forming a cell film onto the surface of the scaffold, limiting 
the infiltration of cells deeply inside.
We also analyzed the osteogenic differentiation of 
the human osteoblasts and hMSCs in the presence of 
(CHI/BMP-7)
4
 nanoreservoirs. Osteopontin and BSPII are 
proteins secreted in an early stage of the bone formation pro-
cess, thus their expression onto both NF and NR4 scaffolds 
shows that bone formation was accelerated for human osteo-
blasts by the scaffold structure. However, the in vitro analysis 
does not enable us to conclude that the functionalization 
of the thick nanofibrous PCL scaffold with (CHI/BMP-7)
4
 
nanocontainers has an enhanced effect on bone induction 
compared to the bare scaffold.
After in vivo model experimentation, however, our results 
evidently confirmed excellent osteoinduction of our 3D nano-
fibrous implants. After 30 days’ implantation, colonization, 
migration, and even mineralization had already occurred deep 
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inside the implant within NR4 compared to NF thick implants 
(Figure 5, pink area), meaning that an accelerating effect of 
the (CHI/BMP-7)
4
 functionalization occurred. The results 
showed that the acceleration effect of the (CHI/BMP-7)
4
 
functionalization positively affected the NR4 implant. 
In vivo implantations confirmed that our thick PCL scaffold 
is biocompatible and nontoxic for living organisms. It was 
well integrated by the host, and, after 30 days of implantation, 
new biomineralized area was detected in the scaffold. The 
Ca/P values suggest that the presence of CHI/BMP-7 nano-
reservoirs enhances bone induction. These results could be 
explained by the increase in the bone regeneration speed due 
to the treatment with CHI/BMP-7. Our results clearly indicate 
that, by the incorporation of BMP-7 as nanoreservoirs for 
cells, bone regeneration was accelerated three times after 
30 days; however, complete bone regeneration was not yet 
achieved (Figure 6). We have as well shown that results in the 
nanoindentation experiments for the NR4 implant is greater 
compared to the NF implant. This could be explained by the 
action of the active nanoreservoirs of BMP-7 onto the nano-
fibers of the NR4 implant (Figure 3) during cell colonization, 
differentiation, and bone growth. However, after 30 days’ 
implantation, using the thick implant, the bone regeneration 
is still not sufficient. To further accelerate the speed of bone 
regeneration, we combined both growth factors and living 
cells. In this study, hMSCs derived from bone marrow were 
used to improve robust bone formation.
Thick PCL nanofibrous implant equipped 
with BMP-7 and hMscs to improve 
robust bone engineering
The objective of this study was to analyze the ability of the 
living implants to accelerate osteogenic differentiation and 
bone regeneration. For this aim, we used thick PCL nano-
fibrous implants seeded with hMSCs derived from bone 
marrow without or with active nanoreservoirs of BMP-7 
and followed bone regeneration in vitro and in vivo in mice. 
Although expression of BSPII and osteocalcin of hMSCs 
occurred at an early stage on both scaffolds, the in vitro model 
does not enable us to establish a significant enhancement 
effect of the NR4 nanofunctionalization, compared to the 
bare scaffold. However, in vivo, we have shown that, after 
adding hMSCs, significant bone growth can be induced by 
our nanocontainers of BMP-7 (NR4) (Figure 9). Here we 
must be clear that the absence of bioactive effect, potentially 
due to CHI instead of BMP-7, has been previously proved in 
experiments involving nanoreservoirs of CHI/BSA (bovine 
serum albumin protein).46 Interestingly, by seeding our NR4 
implant with hMSCs, we found more newly mineralized bone, 
which covered nearly completely the bone defect. Control 
groups comprising NR4 scaffold-only implants without 
adding stem cells resulted only in partial remineralization. 
These results point to an increase in the bone regeneration 
speed due to the double functionalization with BMP-7 and 
living stem cells.
Conclusion
Nanostructured and living biomaterials, by incorporation 
of active therapeutics and stem cells, for use in surgi-
cal implantations, could lead to shorter recovery times 
and decreased risk of postoperative infections or other 
complications. Such innovative technology will improve 
quality of life and could reduce costs. Herein, we reported 
the development and therapeutic impact of advanced liv-
ing implants combining nanostructured biomaterials with 
hMSCs, which resulted in superior bone formation in vivo 
throughout a thick electrospun nanofibrous PCL scaffold. 
The bifunctionalized living implant depicted in this article 
enables accelerated bone regeneration in vivo, this being a 
positive aspect to avoid inflammation in the implantation site. 
Its nanoreservoirs provide a sustainable source of growth 
factor for the osteoconductive cells, which is financially and 
physiologically beneficial for the future patient, as it enables 
efficient low-dose action, compared to current alternatives 
in the clinic. Above all, it enables regeneration in large-size 
defects, which was the challenge to tackle. We believe that 
this double functionalization could lead to a new generation 
of engineered bone implants. This concept could be used for 
other tissue engineering applications.
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Figure S1 In vitro metabolic activity of MSCs on the nanofunctionalized PCL scaffold.
Notes: % alamarBlue® reduction on the thick nanofiber implant without BMP-7 (NF) or NR4 implant at 3 days, 7 days, and 14 days. n=9, P0.05 each time. Scale bars = 
standard deviation.
Abbreviations: MSCs, mesenchymal stem cells; NF, not functionalized; NR4, functionalized with (chitosan/BMP-7)4 nanocontainers; Pcl, poly(ε-caprolactone).
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Figure S2 In vitro expression of OCN, OPN, and BSPII in hMSCs after 21 days of cell culture on bare PCL 3D scaffolds (NF) or those equipped with BMP-7 nanocontainers 
(Nr4).
Notes: Nucleus was stained with DAPI (in blue), actin-phalloidin (in red), and OCN, OPN, and BSPII were stained in green. For all images, scale bars =50 μm.
Abbreviations: BSPII, bone sialoprotein II; hMSCs, human mesenchymal stem cells; NF, not functionalized; NR4, functionalized with (chitosan/BMP-7)4 nanocontainers; 
OcN, osteocalcin; OPN, osteopontin; Pcl, poly(ε-caprolactone).
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